Current advances in multiple sclerosis immunopathology
نویسندگان
چکیده
منابع مشابه
Multiple Sclerosis: Immunopathology and Treatment Update
The treatment of multiple sclerosis (MS) has changed over the last 20 years. All immunotherapeutic drugs target relapsing remitting MS (RRMS) and it still remains a medical challenge in MS to develop a treatment for progressive forms. The most common injectable disease-modifying therapies in RRMS include β-interferons 1a or 1b and glatiramer acetate. However, one of the major challenges of inje...
متن کاملAdvances in Multiple Sclerosis 2017
Multiple sclerosis (MS) is one of the most emerging fields in neurology[...].
متن کاملPromoting Remyelination in Multiple Sclerosis—Recent Advances
We review the current state of knowledge of remyelination in multiple sclerosis (MS), concentrating on advances in the understanding of the pathology and the regenerative response, and we summarise progress on the development of new therapies to enhance remyelination aimed at reducing progressive accumulation of disability in MS. We discuss key target pathways identified in experimental models,...
متن کاملMultiple sclerosis: current treatment algorithms.
PURPOSE OF REVIEW Multiple sclerosis (MS) is an inflammatory autoimmune disorder of the central nervous system. Currently, there are different formulations approved for MS treatment and others are in different stages of investigation or awaiting approval by federal agencies. RECENT FINDINGS All of these medications have demonstrated partial efficacy along with different side-effect profiles. ...
متن کاملCurrent therapy of multiple sclerosis.
The list of medications for both immune modulation and symptomatic relief continues to grow. Ideally, however, drug therapy should be part of a multidisciplinary approach that also includes such elements as patient education and physical therapy.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gaceta de M�xico
سال: 2019
ISSN: 0016-3813
DOI: 10.24875/gmm.m18000194